{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:03:25Z","timestamp":1792112605903,"version":"4.4.0"},"reference-count":141,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T00:00:00Z","timestamp":1600646400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["DOC 31-B26"],"award-info":[{"award-number":["DOC 31-B26"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>In the general population, the ability of high-density lipoproteins (HDLs) to promote cholesterol efflux is a predictor of cardiovascular events, independently of HDL cholesterol levels. Although patients with chronic kidney disease (CKD) have a high burden of cardiovascular morbidity and mortality, neither serum levels of HDL cholesterol, nor cholesterol efflux capacity associate with cardiovascular events. Important for the following discussion on the role of HDL in CKD is the notion that traditional atherosclerotic cardiovascular risk factors only partially account for this increased incidence of cardiovascular disease in CKD. As a potential explanation, across the spectrum of cardiovascular disease, the relative contribution of atherosclerotic cardiovascular disease becomes less important with advanced CKD. Impaired renal function directly affects the metabolism, composition and functionality of HDL particles. HDLs themselves are a heterogeneous population of particles with distinct sizes and protein composition, all of them affecting the functionality of HDL. Therefore, a more specific approach investigating the functional and compositional features of HDL subclasses might be a valuable strategy to decipher the potential link between HDL, cardiovascular disease and CKD. This review summarizes the current understanding of the relationship of HDL composition, metabolism and function to their cardio-protective properties in CKD, with a focus on CKD-induced changes in the HDL proteome and reverse cholesterol transport capacity. We also will highlight the gaps in the current knowledge regarding important aspects of HDL biology.<\/jats:p>","DOI":"10.3390\/biom10091348","type":"journal-article","created":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T21:01:21Z","timestamp":1600722081000},"page":"1348","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Current Understanding of the Relationship of HDL Composition, Structure and Function to Their Cardioprotective Properties in Chronic Kidney Disease"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2422-5381","authenticated-orcid":false,"given":"Gunther","family":"Marsche","sequence":"first","affiliation":[{"name":"Otto Loewi Research Center, Division of Pharmacology, Medical University of Graz, 8010 Graz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar H.","family":"Heine","sequence":"additional","affiliation":[{"name":"Agaplesion Markus Krankenhaus, 60431 Frankfurt, Germany"},{"name":"Faculty of Medicine, Saarland University, D-66424 Homburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1156-631X","authenticated-orcid":false,"given":"Julia T.","family":"Stadler","sequence":"additional","affiliation":[{"name":"Otto Loewi Research Center, Division of Pharmacology, Medical University of Graz, 8010 Graz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Holzer","sequence":"additional","affiliation":[{"name":"Otto Loewi Research Center, Division of Pharmacology, Medical University of Graz, 8010 Graz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,9,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0140-6736(14)61217-4","article-title":"HDL and cardiovascular disease","volume":"384","author":"Rader","year":"2014","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S189","DOI":"10.1194\/jlr.R800088-JLR200","article-title":"The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis","volume":"50","author":"Rader","year":"2009","journal-title":"J. Lipid Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"107459","DOI":"10.1016\/j.pharmthera.2019.107459","article-title":"Lipid-modifying therapy in chronic kidney disease: Pathophysiological and clinical considerations","volume":"207","author":"Heine","year":"2020","journal-title":"Pharm. Ther."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/sdi.12706","article-title":"ESRD-induced dyslipidemia-Should management of lipid disorders differ in dialysis patients?","volume":"31","author":"Moradi","year":"2018","journal-title":"Semin. Dial."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1253\/circj.CJ-13-1025","article-title":"High-density lipoproteins. Multifunctional but vulnerable protections from atherosclerosis","volume":"77","author":"Annema","year":"2013","journal-title":"Circ. J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.pharmthera.2012.12.001","article-title":"Inflammation alters HDL composition and function: Implications for HDL-raising therapies","volume":"137","author":"Marsche","year":"2013","journal-title":"Pharm. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jacl.2013.08.001","article-title":"High-density lipoproteins: A consensus statement from the National Lipid Association","volume":"7","author":"Toth","year":"2013","journal-title":"J. Clin. Lipidol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1194\/jlr.R036095","article-title":"Unraveling the complexities of the HDL lipidome","volume":"54","author":"Kontush","year":"2013","journal-title":"J. Lipid Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1194\/jlr.R035725","article-title":"Proteomic diversity of high density lipoproteins: Our emerging understanding of its importance in lipid transport and beyond","volume":"54","author":"Shah","year":"2013","journal-title":"J. Lipid Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"158686","DOI":"10.1016\/j.bbalip.2020.158686","article-title":"Lysophosphatidylcholines inhibit human eosinophil activation and suppress eosinophil migration in vivo","volume":"1865","author":"Knuplez","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1681\/ASN.2010111144","article-title":"Uremia alters HDL composition and function","volume":"22","author":"Holzer","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1681\/ASN.2011070668","article-title":"Serum Amyloid A in Uremic HDL Promotes Inflammation","volume":"23","author":"Weichhart","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1681\/ASN.2014030309","article-title":"Dialysis Modalities and HDL Composition and Function","volume":"26","author":"Holzer","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.jacc.2012.09.013","article-title":"Dysfunctional high-density lipoprotein in patients on chronic hemodialysis","volume":"60","author":"Yamamoto","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1681\/ASN.2013111212","article-title":"HDL in children with CKD promotes endothelial dysfunction and an abnormal vascular phenotype","volume":"25","author":"Shroff","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"41481","DOI":"10.1038\/srep41481","article-title":"High density lipoprotein (HDL) particles from end-stage renal disease patients are defective in promoting reverse cholesterol transport","volume":"7","author":"Anderson","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1056\/NEJMoa1409065","article-title":"HDL cholesterol efflux capacity and incident cardiovascular events","volume":"371","author":"Rohatgi","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S2213-8587(15)00126-6","article-title":"Association of HDL cholesterol efflux capacity with incident coronary heart disease events: A prospective case-control study","volume":"3","author":"Saleheen","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jacc.2016.10.054","article-title":"HDL Cholesterol Efflux Capacity and Cardiovascular Events in Patients With Chronic Kidney Disease","volume":"69","author":"Bauer","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jacc.2018.05.043","article-title":"Impaired Renal Function on Cholesterol Efflux Capacity, HDL Particle Number, and Cardiovascular Events","volume":"72","author":"Chindhy","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1681\/ASN.2016030262","article-title":"HDL Cholesterol Efflux Does Not Predict Cardiovascular Risk in Hemodialysis Patients","volume":"28","author":"Kopecky","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1161\/CIRCULATIONAHA.111.020982","article-title":"Chronic kidney disease is associated with the incidence of atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) study","volume":"123","author":"Alonso","year":"2011","journal-title":"Circulation"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1681\/ASN.2006101159","article-title":"Reduced kidney function as a risk factor for incident heart failure: The atherosclerosis risk in communities (ARIC) study","volume":"18","author":"Kottgen","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.kint.2019.07.012","article-title":"A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases","volume":"96","author":"Jager","year":"2019","journal-title":"Kidney Int."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S2213-8587(15)00040-6","article-title":"CKD Prognosis Consortium Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: A collaborative meta-analysis of individual participant data","volume":"3","author":"Matsushita","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1001\/jama.2009.1488","article-title":"Cardiovascular and noncardiovascular mortality among patients starting dialysis","volume":"302","author":"Grootendorst","year":"2009","journal-title":"JAMA"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"ESC Scientific Document Group 2019 ESC\/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2019","journal-title":"Eur. Heart J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","article-title":"ESC Scientific Document Group 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"German Diabetes and Dialysis Study Investigators Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0140-6736(03)13638-0","article-title":"Assessment of LEscol in Renal Transplantation (ALERT) Study Investigators Effect of fluvastatin on cardiac outcomes in renal transplant recipients: A multicentre, randomised, placebo-controlled trial","volume":"361","author":"Holdaas","year":"2003","journal-title":"Lancet"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa0810177","article-title":"AURORA Study Group Rosuvastatin and cardiovascular events in patients undergoing hemodialysis","volume":"360","author":"Fellstrom","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"SHARP Investigators The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): A randomised placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/sdi.12621","article-title":"Still a reasonable goal: Targeting cholesterol in dialysis and advanced chronic kidney disease patients","volume":"30","author":"Heine","year":"2017","journal-title":"Semin. Dial."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.2215\/CJN.09121010","article-title":"German Diabetes and Dialysis Study Investigators Atorvastatin and low-density lipoprotein cholesterol in type 2 diabetes mellitus patients on hemodialysis","volume":"6","author":"Marz","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S2213-8587(19)30388-2","article-title":"Intensive LDL cholesterol-lowering treatment beyond current recommendations for the prevention of major vascular events: A systematic review and meta-analysis of randomised trials including 327 037 participants","volume":"8","author":"Wang","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1093\/eurheartj\/ehx163","article-title":"Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: Two prospective cohort studies","volume":"38","author":"Madsen","year":"2017","journal-title":"Eur. Heart J."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Feng, M., Darabi, M., Tubeuf, E., Canicio, A., Lhomme, M., Frisdal, E., Lanfranchi-Lebreton, S., Matheron, L., Rached, F., and Ponnaiah, M. (2019). Free cholesterol transfer to high-density lipoprotein (HDL) upon triglyceride lipolysis underlies the U-shape relationship between HDL-cholesterol and cardiovascular disease. Eur. J. Prev. Cardiol.","DOI":"10.1177\/2047487319894114"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/11914","article-title":"The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease","volume":"22","author":"Bodzioch","year":"1999","journal-title":"Nat. Genet."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1194\/jlr.S120000720","article-title":"Lecithin: Cholesterol Acyltransferase: Symposium on 50-years of biomedical research from its discovery to latest findings","volume":"61","author":"Norum","year":"2020","journal-title":"J. Lipid Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1194\/jlr.RA120000691","article-title":"The lipid transfer properties of CETP define the concentration and composition of plasma lipoproteins","volume":"61","author":"Morton","year":"2020","journal-title":"J. Lipid Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1194\/jlr.M001875","article-title":"Analysis of lipid transfer activity between model nascent HDL particles and plasma lipoproteins: Implications for current concepts of nascent HDL maturation and genesis","volume":"51","author":"Bailey","year":"2010","journal-title":"J. Lipid Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/00041433-200010000-00007","article-title":"ABC transporters in cellular lipid trafficking","volume":"11","author":"Schmitz","year":"2000","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"29993","DOI":"10.1074\/jbc.275.39.29993","article-title":"Scavenger receptor class B, type I-mediated [3H]cholesterol efflux to high and low density lipoproteins is dependent on lipoprotein binding to the receptor","volume":"275","author":"Gu","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1161\/ATVBAHA.109.196105","article-title":"Pathways by which reconstituted high-density lipoprotein mobilizes free cholesterol from whole body and from macrophages","volume":"30","author":"Cuchel","year":"2010","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"12610","DOI":"10.1073\/pnas.94.23.12610","article-title":"A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism","volume":"94","author":"Rigotti","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1194\/jlr.M800434-JLR200","article-title":"Hepatic SR-BI, not endothelial lipase, expression determines biliary cholesterol secretion in mice","volume":"50","author":"Wiersma","year":"2009","journal-title":"J. Lipid Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/MOL.0b013e3283395e45","article-title":"Transintestinal cholesterol efflux","volume":"21","author":"Brufau","year":"2010","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1021\/bi00768a015","article-title":"Studies of the composition and structure of plasma lipoproteins. Separation and quantification of the lipoprotein families occurring in the high density lipoproteins of human plasma","volume":"11","author":"Kostner","year":"1972","journal-title":"Biochemistry"},{"key":"ref_49","first-page":"145","article-title":"Peptide composition of human plasma apolipoproteins A, B and C","volume":"31","author":"Alaupovic","year":"1972","journal-title":"Expos Annu. Biochim. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1124\/pr.58.3.1","article-title":"Functionally defective high-density lipoprotein: A new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis","volume":"58","author":"Kontush","year":"2006","journal-title":"Pharm. Rev."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-319-09665-0_1","article-title":"Structure of HDL: Particle subclasses and molecular components","volume":"224","author":"Kontush","year":"2015","journal-title":"Handb. Exp. Pharm."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1161\/ATVBAHA.109.186031","article-title":"Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: Relevance to antioxidative function","volume":"29","author":"Davidson","year":"2009","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/MOL.0b013e3283468061","article-title":"Metabolic and functional relevance of HDL subspecies","volume":"22","author":"Asztalos","year":"2011","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0076-6879(86)28084-2","article-title":"Nondenaturing polyacrylamide gradient gel electrophoresis","volume":"128","author":"Nichols","year":"1986","journal-title":"Methods Enzymol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cll.2006.07.006","article-title":"Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy","volume":"26","author":"Jeyarajah","year":"2006","journal-title":"Clin. Lab. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1681\/ASN.2013050482","article-title":"HDL cholesterol is not associated with lower mortality in patients with kidney dysfunction","volume":"25","author":"Zewinger","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1681\/ASN.2013080816","article-title":"HDL cholesterol, apolipoproteins, and cardiovascular risk in hemodialysis patients","volume":"26","author":"Silbernagel","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/ndt\/gfu022","article-title":"Elevated high-density lipoprotein cholesterol and cardiovascular mortality in maintenance hemodialysis patients","volume":"29","author":"Moradi","year":"2014","journal-title":"Nephrol. Dial. Transpl."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/joim.12290","article-title":"Acquired lecithin:cholesterol acyltransferase deficiency as a major factor in lowering plasma HDL levels in chronic kidney disease","volume":"277","author":"Calabresi","year":"2015","journal-title":"J. Intern Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/01.ASN.0000046962.43220.8A","article-title":"LCAT-dependent conversion of prebeta1-HDL into alpha-migrating HDL is severely delayed in hemodialysis patients","volume":"14","author":"Miida","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1053\/ajkd.2001.27384","article-title":"Abnormalities in uremic lipoprotein metabolism and its impact on cardiovascular disease","volume":"38","author":"Quaschning","year":"2001","journal-title":"Am. J. Kidney. Dis."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Kuchta, A., Cwiklinska, A., Czaplinska, M., Wieczorek, E., Kortas-Stempak, B., Gliwinska, A., Dabkowski, K., Salaga-Zaleska, K., Mickiewicz, A., and Debska-Slizien, A. (2019). Plasma Levels of Prebeta1-HDL Are Significantly Elevated in Non-Dialyzed Patients with Advanced Stages of Chronic Kidney Disease. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20051202"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1053\/j.jrn.2008.10.011","article-title":"Lipid and lipoprotein metabolism in chronic kidney disease","volume":"19","author":"Kaysen","year":"2009","journal-title":"J. Ren. Nutr."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1194\/jlr.P900003-JLR200","article-title":"Chronic kidney disease delays VLDL-apoB-100 particle catabolism: Potential role of apolipoprotein C-III","volume":"50","author":"Chan","year":"2009","journal-title":"J. Lipid Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1194\/jlr.M011163","article-title":"Plasma apolipoprotein C-III metabolism in patients with chronic kidney disease","volume":"52","author":"Ooi","year":"2011","journal-title":"J. Lipid Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1172\/JCI86610","article-title":"ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors","volume":"126","author":"Gordts","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ki.1996.186","article-title":"Advanced oxidation protein products as a novel marker of oxidative stress in uremia","volume":"49","author":"Friedlander","year":"1996","journal-title":"Kidney Int."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1161\/CIRCRESAHA.108.193169","article-title":"Plasma-advanced oxidation protein products are potent high-density lipoprotein receptor antagonists in vivo","volume":"104","author":"Marsche","year":"2009","journal-title":"Circ. Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1161\/ATVBAHA.113.301235","article-title":"The myeloperoxidase product hypochlorous acid generates irreversible high-density lipoprotein receptor inhibitors","volume":"33","author":"Binder","year":"2013","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1053\/ajkd.2002.29883","article-title":"Fluvastatin improves lipid abnormalities in patients with moderate to advanced chronic renal insufficiency","volume":"39","author":"Samuelsson","year":"2002","journal-title":"Am. J. Kidney Dis."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/jcph.1337","article-title":"Moderate Renal Impairment Does Not Impact the Ability of CSL112 (Apolipoprotein A-I [Human]) to Enhance Cholesterol Efflux Capacity","volume":"59","author":"Gille","year":"2019","journal-title":"J. Clin. Pharm."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"F823","DOI":"10.1152\/ajprenal.2001.280.5.F823","article-title":"Acquired lecithin-cholesterol acyltransferase deficiency in nephrotic syndrome","volume":"280","author":"Vaziri","year":"2001","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0021-9150(01)00728-6","article-title":"Changes in plasma lecithin: Cholesterol acyltransferase activity, HDL(2), HDL(3) amounts and compositions in patients with chronic renal failure after different times of hemodialysis","volume":"162","author":"Mekki","year":"2002","journal-title":"Atherosclerosis"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/ki.1984.74","article-title":"Plasma lipoproteins and lecithin:cholesterol acyltransferase distribution in patients on dialysis","volume":"25","author":"McLeod","year":"1984","journal-title":"Kidney Int."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.clinbiochem.2018.08.006","article-title":"Activity of paraoxonase 1 (PON1) on HDL2 and HDL3 subclasses in renal disease","volume":"60","author":"Miljkovic","year":"2018","journal-title":"Clin. Biochem."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000351506","article-title":"Skew of plasma low- and high-density lipoprotein distributions to less dense subfractions in normotriglyceridemic chronic kidney disease patients on maintenance hemodialysis treatment","volume":"123","author":"Homma","year":"2013","journal-title":"Nephron Clin. Pract."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.cca.2012.09.028","article-title":"Shift of high-density lipoprotein size distribution toward large particles in patients with proteinuria","volume":"414","author":"Lorenzo","year":"2012","journal-title":"Clin. Chim. Acta"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1515\/jomb-2017-0019","article-title":"Alterations of HDL Particles in Children with End-stage Renal Disease","volume":"36","author":"Stefanovic","year":"2017","journal-title":"J. Med. Biochem."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0009-9120(02)00300-4","article-title":"LDL and HDL subclass distribution in patients with end-stage renal diseases","volume":"35","author":"Alabakovska","year":"2002","journal-title":"Clin. Biochem."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/oxfordjournals.ndt.a027068","article-title":"Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failure","volume":"11","author":"Attman","year":"1996","journal-title":"Nephrol. Dial. Transpl."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/cvr\/cvs089","article-title":"High-density lipoprotein loses its anti-inflammatory capacity by accumulation of pro-inflammatory-serum amyloid A","volume":"94","author":"Tolle","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1681\/ASN.2013111219","article-title":"Restoration of renal function does not correct impairment of uremic HDL properties","volume":"26","author":"Kopecky","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/j.kint.2017.05.020","article-title":"Kidney function is associated with an altered protein composition of high-density lipoprotein","volume":"92","author":"Rubinow","year":"2017","journal-title":"Kidney Int."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Mange, A., Goux, A., Badiou, S., Patrier, L., Canaud, B., Maudelonde, T., Cristol, J.P., and Solassol, J. (2012). HDL proteome in hemodialysis patients: A quantitative nanoflow liquid chromatography-tandem mass spectrometry approach. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0034107"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1021\/acs.jproteome.5b00060","article-title":"A Cluster of Proteins Implicated in Kidney Disease Is Increased in High-Density Lipoprotein Isolated from Hemodialysis Subjects","volume":"14","author":"Shao","year":"2015","journal-title":"J. Proteome Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.2215\/CJN.11321017","article-title":"HFM Study Alteration of HDL Protein Composition with Hemodialysis Initiation","volume":"13","author":"Wang","year":"2018","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Florens, N., Calzada, C., Delolme, F., Page, A., Guebre Egziabher, F., Juillard, L., and Soulage, A.C.O. (2019). Proteomic Characterization of High-Density Lipoprotein Particles from Non-Diabetic Hemodialysis Patients. Toxins, 11.","DOI":"10.3390\/toxins11110671"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1681\/ASN.2017070798","article-title":"HDL in CKD-The Devil Is in the Detail","volume":"29","author":"Kronenberg","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1172\/JCI118345","article-title":"Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures","volume":"96","author":"Hama","year":"1995","journal-title":"J. Clin. Investig."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1365-2362.1996.159291.x","article-title":"Human serum amyloid A (SAA) protein: A prominent acute-phase reactant for clinical practice","volume":"26","author":"Malle","year":"1996","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1084\/jem.180.1.203","article-title":"Serum amyloid A is a chemoattractant: Induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes","volume":"180","author":"Badolato","year":"1994","journal-title":"J. Exp. Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.4049\/jimmunol.178.3.1852","article-title":"Serum amyloid A induces monocyte tissue factor","volume":"178","author":"Cai","year":"2007","journal-title":"J. Immunol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.4049\/jimmunol.181.6.4332","article-title":"Serum amyloid A induces CCL2 production via formyl peptide receptor-like 1-mediated signaling in human monocytes","volume":"181","author":"Lee","year":"2008","journal-title":"J. Immunol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1161\/ATVBAHA.111.226159","article-title":"Serum amyloid A facilitates the binding of high-density lipoprotein from mice injected with lipopolysaccharide to vascular proteoglycans","volume":"31","author":"Chiba","year":"2011","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fimmu.2013.00092","article-title":"Endogenous Acute Phase Serum Amyloid A Lacks Pro-Inflammatory Activity, Contrasting the Two Recombinant Variants That Activate Human Neutrophils through Different Receptors","volume":"4","author":"Christenson","year":"2013","journal-title":"Front. Immunol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1189\/jlb.0607-408","article-title":"Serum amyloid A mediates human neutrophil production of reactive oxygen species through a receptor independent of formyl peptide receptor like-1","volume":"83","author":"Bjorkman","year":"2008","journal-title":"J. Leukoc. Biol."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Cheng, N., Liang, Y., Du, X., and Ye, R.D. (2018). Serum amyloid A promotes LPS clearance and suppresses LPS-induced inflammation and tissue injury. EMBO Rep., 19.","DOI":"10.15252\/embr.201745517"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Murdoch, C.C., Espenschied, S.T., Matty, M.A., Mueller, O., Tobin, D.M., and Rawls, J.F. (2019). Intestinal Serum amyloid A suppresses systemic neutrophil activation and bactericidal activity in response to microbiota colonization. PLoS Pathog., 15.","DOI":"10.1371\/journal.ppat.1007381"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jsb.2017.06.007","article-title":"Serum amyloid A self-assembles with phospholipids to form stable protein-rich nanoparticles with a distinct structure: A hypothetical function of SAA as a \"molecular mop\" in immune response","volume":"200","author":"Frame","year":"2017","journal-title":"J. Struct. Biol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jacl.2015.05.002","article-title":"The risk of cardiovascular events with increased apolipoprotein CIII: A systematic review and meta-analysis","volume":"9","author":"Haring","year":"2015","journal-title":"J. Clin. Lipidol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1373\/clinchem.2008.103234","article-title":"Increased plasma apolipoprotein C-III concentration independently predicts cardiovascular mortality: The Hoorn Study","volume":"54","author":"Scheffer","year":"2008","journal-title":"Clin. Chem."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"e013713","DOI":"10.1161\/JAHA.119.013713","article-title":"Association of High-Density Lipoprotein Particles and High-Density Lipoprotein Apolipoprotein C-III Content With Cardiovascular Disease Risk According to Kidney Function: The Multi-Ethnic Study of Atherosclerosis","volume":"8","author":"McClelland","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"ref_103","first-page":"1","article-title":"ApoCIII enrichment in HDL impairs HDL-mediated cholesterol efflux capacity","volume":"7","author":"Luo","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41590-019-0548-1","article-title":"Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation","volume":"21","author":"Zewinger","year":"2020","journal-title":"Nat. Immunol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1161\/CIRCULATIONAHA.106.622514","article-title":"Apolipoprotein CIII induces expression of vascular cell adhesion molecule-1 in vascular endothelial cells and increases adhesion of monocytic cells","volume":"114","author":"Kawakami","year":"2006","journal-title":"Circulation"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1161\/01.ATV.0000249620.68705.0d","article-title":"Apolipoprotein CIII-induced THP-1 cell adhesion to endothelial cells involves pertussis toxin-sensitive G protein- and protein kinase C alpha-mediated nuclear factor-kappaB activation","volume":"27","author":"Kawakami","year":"2007","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/cvr\/cvv192","article-title":"Aggravated restenosis and atherogenesis in ApoCIII transgenic mice but lack of protection in ApoCIII knockouts: The effect of authentic triglyceride-rich lipoproteins with and without ApoCIII","volume":"107","author":"Li","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/all.13620","article-title":"Abnormal composition and function of high-density lipoproteins in atopic dermatitis patients","volume":"74","author":"Trieb","year":"2019","journal-title":"Allergy"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.bbalip.2019.06.007","article-title":"Allergic rhinitis is associated with complex alterations in high-density lipoprotein composition and function","volume":"1864","author":"Trakaki","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clinbiochem.2019.07.010","article-title":"The epigenetic regulation of paraoxonase 1 (PON1) as an important enzyme in HDL function: The missing link between environmental and genetic regulation","volume":"73","author":"Mahrooz","year":"2019","journal-title":"Clin. Biochem."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cbi.2016.05.036","article-title":"Paraoxonases-1, -2 and -3: What are their functions?","volume":"259","author":"Furlong","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1194\/jlr.M200432-JLR200","article-title":"Serum paraoxonase: Effect of the apolipoprotein composition of HDL and the acute phase response","volume":"44","author":"Cabana","year":"2003","journal-title":"J. Lipid Res."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/10408360802610878","article-title":"The paraoxonases: Role in human diseases and methodological difficulties in measurement","volume":"46","author":"Camps","year":"2009","journal-title":"Crit. Rev Clin. Lab. Sci."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1210\/jc.2019-00334","article-title":"Association of Serum Paraoxonase\/Arylesterase Activity With All-Cause Mortality in Maintenance Hemodialysis Patients","volume":"104","author":"Suematsu","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"726048","DOI":"10.1155\/2012\/726048","article-title":"Paraoxonase 1 in chronic kidney failure","volume":"2012","author":"Gugliucci","year":"2012","journal-title":"J. Lipids"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1194\/jlr.P085076","article-title":"HDL functionality and cardiovascular outcome among nondialysis chronic kidney disease patients","volume":"59","author":"Untersteller","year":"2018","journal-title":"J. Lipid Res."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2165\/00129784-200404040-00002","article-title":"The role of paraoxonase 1 activity in cardiovascular disease: Potential for therapeutic intervention","volume":"4","author":"Mackness","year":"2004","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1161\/01.ATV.0000222924.62641.aa","article-title":"Human paraoxonase-1 overexpression inhibits atherosclerosis in a mouse model of metabolic syndrome","volume":"26","author":"Mackness","year":"2006","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.atherosclerosis.2004.10.028","article-title":"Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter in association with increased HDL binding to the cells: A possible role for lysophosphatidylcholine","volume":"179","author":"Rosenblat","year":"2005","journal-title":"Atherosclerosis"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1161\/01.ATV.0000057572.97137.DD","article-title":"Importance of different pathways of cellular cholesterol efflux","volume":"23","author":"Yancey","year":"2003","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"17106","DOI":"10.1074\/jbc.270.29.17106","article-title":"Effects of acceptor particle size on the efflux of cellular free cholesterol","volume":"270","author":"Davidson","year":"1995","journal-title":"J. Biol. Chem."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1172\/JCI35470","article-title":"ABCG1 and HDL protect against endothelial dysfunction in mice fed a high-cholesterol diet","volume":"118","author":"Terasaka","year":"2008","journal-title":"J. Clin. Investig."},{"key":"ref_123","first-page":"3900","article-title":"Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice","volume":"117","author":"Ranalletta","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1194\/jlr.D075366","article-title":"HDL structure and function is profoundly affected when stored frozen in the absence of cryoprotectants","volume":"58","author":"Holzer","year":"2017","journal-title":"J. Lipid Res."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1161\/ATVBAHA.109.199158","article-title":"The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages","volume":"30","author":"Asztalos","year":"2010","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa1001689","article-title":"Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis","volume":"364","author":"Khera","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.atherosclerosis.2015.10.111","article-title":"Cholesterol efflux capacity is an independent predictor of all-cause and cardiovascular mortality in patients with coronary artery disease: A prospective cohort study","volume":"249","author":"Liu","year":"2015","journal-title":"Atherosclerosis"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.2337\/db18-1267","article-title":"High Density Lipoprotein Cholesterol Efflux Predicts Incident New Onset Diabetes After Transplantation (NODAT) in Renal Transplant Recipients Independent of High Density Lipoprotein Cholesterol Levels","volume":"68","author":"Annema","year":"2019","journal-title":"Diabetes"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1194\/jlr.M800362-JLR200","article-title":"Effects of acceptor composition and mechanism of ABCG1-mediated cellular free cholesterol efflux","volume":"50","author":"Sankaranarayanan","year":"2009","journal-title":"J. Lipid Res."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1161\/01.ATV.20.3.763","article-title":"Role of serum amyloid A during metabolism of acute-phase HDL by macrophages","volume":"20","author":"Artl","year":"2000","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1681\/ASN.2014090857","article-title":"HDL Cholesterol Efflux Predicts Graft Failure in Renal Transplant Recipients","volume":"27","author":"Annema","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"702","DOI":"10.2215\/CJN.04360418","article-title":"IL-1 Inhibition and Function of the HDL-Containing Fraction of Plasma in Patients with Stages 3 to 5 CKD","volume":"14","author":"Hung","year":"2019","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.immuni.2013.02.009","article-title":"Abnormal high-density lipoprotein induces endothelial dysfunction via activation of Toll-like receptor-2","volume":"38","author":"Speer","year":"2013","journal-title":"Immunity"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/MOL.0b013e32833bcdc1","article-title":"Antiatherogenic function of HDL particle subpopulations: Focus on antioxidative activities","volume":"21","author":"Kontush","year":"2010","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1681\/ASN.V9112082","article-title":"Decrease of serum paraoxonase activity in chronic renal failure","volume":"9","author":"Dantoine","year":"1998","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/ndt\/gfl007","article-title":"Respective role of uraemic toxins and myeloperoxidase in the uraemic state","volume":"21","author":"Gausson","year":"2006","journal-title":"Nephrol. Dial. Transpl."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1681\/ASN.2012030254","article-title":"Protein Carbamylation Predicts Mortality in ESRD","volume":"24","author":"Koeth","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/nm1637","article-title":"Protein carbamylation links inflammation, smoking, uremia and atherogenesis","volume":"13","author":"Wang","year":"2007","journal-title":"Nat. Med."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"F511","DOI":"10.1152\/ajprenal.00508.2015","article-title":"Increased carbamylation level of HDL in end-stage renal disease: Carbamylated-HDL attenuated endothelial cell function","volume":"310","author":"Sun","year":"2016","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1089\/ars.2010.3640","article-title":"Protein Carbamylation Renders High-Density Lipoprotein Dysfunctional","volume":"14","author":"Holzer","year":"2011","journal-title":"Antioxid. Redox Signal."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1089\/ars.2011.4403","article-title":"Myeloperoxidase-Derived Chlorinating Species Induce Protein Carbamylation Through Decomposition of Thiocyanate and Urea: Novel Pathways Generating Dysfunctional High-Density Lipoprotein","volume":"17","author":"Holzer","year":"2012","journal-title":"Antioxid. Redox Signal."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/10\/9\/1348\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:12:10Z","timestamp":1760177530000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/10\/9\/1348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,21]]},"references-count":141,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9]]}},"alternative-id":["biom10091348"],"URL":"https:\/\/doi.org\/10.3390\/biom10091348","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,21]]}}}